The Sumisho Computer Systems Corporation, a Tokyo-based health information technology company, has joined Medidata’s "ASPire To Win" program for contract research organizations and service providers.
Sumisho officials say the partnership will give the company a chance to expand its clinical solution capabilities and expertise. Sumisho looks to provide support to the Medidata Rave electronic data and clinical data management solution.
“By joining Medidata’s ASPire to Win program we will be able to add Medidata Rave-related services to our extensive solution set and bring additional value to sponsors of clinical research,” said Seiichiro Nagaya, general manager of the Sumisho's data science division.
The company offers expertise in IT project management, systems development, configuration and testing as well as clinical data warehousing and analysis solutions. By joining Medidata’s ASPire to Win program, Sumisho expects to be able to offer new Rave-related data management services to clients in healthcare and supporting Medidata customers in Japan and internationally.
Medidata’s ASPire to Win program trains and accredits IT service providers to deliver Medidata Rave clinical trial technology, along with each company’s own data management expertise, on four enablement levels – Rave Aware, Rave Ready, Rave Accredited and Rave Accredited Plus.
“(Sumisho's) deep systems integration expertise will strategically complement the services of our CRO partners already supporting Medidata Rave implementations in Asia,” said Graham Bunn, vice president of global CRO partnership at Medidata Solutions. “Partnering for the first time with a systems integrator broadens the Medidata Rave-related services and systems expertise available to support our growing customer base in Japan and elsewhere in Asia.”
